Yazar "Kutluturkan, Sevinc" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim
    Öğe
    Opinions and Experiences of Patients Receiving Oral Chemotherapy: A Qualitative Study
    (MARMARA UNIV, INST HEALTH SCIENCES, 2020) Kutluturkan, Sevinc; Kirca, Kamile; Yurtal, Ozlem
    Objective: This study is a qualitative study aimed to determine the opinions and experiences of patients receiving oral chemotherapy. Methods: The study was conducted in 2018 with 18 volunteers who admitted to the outpatient oncology clinic of a university hospital and received oral chemotherapy. In data collection, a description form and a semi-structured interview form were used. In data analysis process, transcription after each interview and evaluation steps through thematic content analysis method were employed. COREQ-Consolidated Criteria for Reporting Qualitative research was used in the structuring and reporting phase of the qualitative study. Results: The themes obtained in the study were access to drugs, use of medicine, side effects and control of treatment, approach of health professionals and support of family and relatives. There is a need to ensure the continuity of the treatment follow-up period in order to improve treatment compliance of patients, to monitor side effects of treatment and to ensure safe use of medicines. Conclusion: In this process, it is crucial that nurses take an active role in patient education and counseling among health professionals so that weaknesses in the patient's drug use process and opportunities for improvement could be identified.
  • [ X ]
    Öğe
    Strengths, weaknesses, opportunities and threats analysis of being an oncology nurse: a Turkish oncology nurses' perspective
    (Mark Allen Group, 2022) Kutluturkan, Sevinc; Kirca, Kamile
    Background: Oncology nurses play a key role in providing high-quality treatment and care to cancer patients. Aim: The aim of this study was to determine oncology nurses' views of the strengths, weaknesses, opportunities, and threats to oncology nurses. Methods: This descriptive pilot study was conducted online between December 2018 and January 2019.The study population consisted of 845 nurses who were members of the Oncology Nursing Association of Turkey. The sample consisted of 80 oncology nurses. Data were collected using an online survey. Participants' responses were grouped and evaluated. Data were analysed using numbers and percentages. Results:The mean age of participants was 34.34 +/- 8.23 years.A total of 48 participants (60.5%) were university hospital nurses, and 63 (793%) were medical oncology nurses. Participants had 8.06 +/- 6.72 (mininum I and maximum 22) years of work experience as oncology nurses. For participants, the central strengths of oncology nurses were speed, self-confidence, neatness, composure, patience, compassion or attention (72.4%); psychosocial support (64.5%); and training and consultancy (58.1%). For participants, the first three weaknesses of oncology nurses were over-sentimentality, helplessness or burnout (54.2%); working conditions (50%); and limited knowledge (47.3%). For participants, the first three opportunities of oncology nursing were attending organisations on oncology nursing (62.4%), education and research (50%), and developing patience, strength, empathy, and critical thinking skills (48.6%). For participants, the first three threats to oncology nurses were employee safety issues (76.6%), psychosocial problems (65%) and physical problems (48.8%). Conclusion:Weaknesses and threats should be eliminated for the development of oncology nursing in the light of its strengths and opportunities.
  • Küçük Resim
    Öğe
    Symptoms Experience and Quality of Life in The Patients With Breast Cancer Receiving The Taxane Class of Drugs
    (Aves, 2018) Kirca, Kamile; Kutluturkan, Sevinc
    Objective: The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs. Materials and Methods: This study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 patients, who agreed to participate in the study. The Memorial Symptom Rating Score (MSAS), Socio-demographic and Clinical Features Form, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Breast (EORTC QLQ-BR23) measures specific to breast cancer were used to obtain data. Results: The average age of the patients was 45.65. The majority of patients were treated with the paclitaxel/paclitaxel+trastuzumab treatment protocol (60.42%), and more than half (54.16%) of these patients were on 5 or 6 treatments. The symptoms patients experienced the most commonly included being sensitive, weakness or energy loss and pain. The symptoms they experienced severely were included fatigue and energy loss and being sensitive. The most distressing symptoms were pain, worry, numbness in hands and feet. The overall well-being score of the patients as per the quality of life findings was 46.18 +/- 11.66. While the lowest score for the functional scales was in the social function subscale (66.32 +/- 15.18), the highest score for the symptom scales was in the pain subscale (42.01 +/- 15.37). The lowest score for the EORTC QLQ-BR23 scales was in the sexual life subscale (20.83 +/- 20.19); the highest score was in the body appearance subscale (65.8 +/- 23.96). Conclusion: The results of the study are thought to be helpful for the oncology nurses in evaluating the patients in all aspects and in determining priorities for care.